Table 2.
Summary of results for M + 3
| Whole group (n = 32) |
Non-smokers (n = 15) |
Smokers (n = 17) |
||
|---|---|---|---|---|
| CD34+ | (% of PMBC) | 0.08 ± 0.03 | 0.10 ± 0.03 | 0.06 ± 0.02* |
| CD34+/CD133+ | (% of PMBC) | 0.04 ± 0.02 | 0.05 ± 0.02 | 0.04 ± 0.01 |
| EPC-CFU | (per 106 PBMC) | 27.1 ± 28.0 | 36.5 ± 34.0 | 18.8 ± 18.6 |
| FMD | (%) | 9.2 ± 4.1 | 9.9 ± 4.5% | 8.5 ± 3.7 |
| NMD | (%) | 25.0 ± 7.3 | 24.3 ± 7.2 | 25.7 ± 7.5 |
| Estradiol | (pmol/l) | 151 ± 75 | 175 ± 76 | 130 ± 70 |
| Progesterone | (nmol/l) | 3.86 ± 1.54 | 3.12 ± 1.29 | 4.5 ± 1.48 |
*p < 0.05 for comparison of non-smokers with smokers; values are mean ± SD; CD34+ = progenitor cells positive for haematopoietic stem cell marker CD34; CD34+/CD133+ = progenitor cells positive for hematopoietic stem cell markers CD34 and CD133; EPC-CFU = endothelial progenitor cells analyzed by in vitro formation of colony forming unit; FMD = flow-mediated dilation; NMD = nitro-mediated dilation